Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Is Expanding Transparency Efforts To Focus On Industry Questions

This article was originally published in The Pink Sheet Daily

Executive Summary

Sharfstein said the agency has split up its transparency efforts into three groups, adding one dedicated to explaining its inner workings to regulated industry.
Advertisement

Related Content

Transparency Phase III: FDA Offers Designs For Industry Review
Transparency Phase III: FDA Offers Designs For Industry Review
Where's Your Application? FDA May Soon Have An App For That
Where's Your Application? FDA May Soon Have An App For That
Transparent Timing: Industry Will Soon Learn FDA Thinking On Releasing Info Now Kept Under Wraps
Transparent timing
Jenkins Suggests "Complete Response" Letter Transparency Could Prompt Better Drug Applications, Faster Reviews
FDA's Transparency Initiative Enters The "What Is The Right Thing To Do" Phase: An Interview With Principal Deputy Commissioner Sharfstein
FDA Gets Investor Advice On Transparency At White House Gathering
FDA Gets Investor Advice On Transparency At White House Gathering

Topics

Advertisement
UsernamePublicRestriction

Register

PS068746

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel